Establishment Labs Holdings (ESTA) Cash from Operations (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Establishment Labs Holdings | 2.04 Bn | 1.97 Bn | 42.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,560.49% |
| Dec 31, 2025 | 98.56% |
| Sep 30, 2025 | 40.01% |
| Jun 30, 2025 | 9.52% |
| Mar 31, 2025 | 0.12% |
| Dec 31, 2024 | -66.51% |
| Sep 30, 2024 | 11.96% |
| Jun 30, 2024 | -26.92% |
| Mar 31, 2024 | -36.87% |
| Dec 31, 2023 | 74.14% |
| Sep 30, 2023 | -11.58% |
| Jun 30, 2023 | -36.99% |
| Mar 31, 2023 | -47.07% |
| Dec 31, 2022 | 36.23% |
| Sep 30, 2022 | -94.00% |
| Jun 30, 2022 | -134.09% |
| Mar 31, 2022 | 37.22% |
| Dec 31, 2021 | 38.11% |
| Sep 30, 2021 | -1,430.10% |
| Jun 30, 2021 | 87.58% |
| Mar 31, 2021 | -290.86% |
| Dec 31, 2020 | 212.70% |
| Sep 30, 2020 | 50.01% |
| Jun 30, 2020 | 10.39% |
| Mar 31, 2020 | -68.95% |
| Dec 31, 2019 | 63.05% |
| Sep 30, 2019 | -54.27% |
| Jun 30, 2019 | 11.69% |
| Mar 31, 2019 | 5.68% |
| Dec 31, 2018 | 19.20% |
| Sep 30, 2018 | -16.88% |
| Jun 30, 2018 | -51.39% |
| Mar 31, 2018 | 27.16% |
| Dec 31, 2017 | 9.84% |